News Sentiment

CUV sentiment intelligence

Clinuvel Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 17 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 10.30 Week of 19 Jun 2026
Weighted tone 56/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+15.0% over one week, +13.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Is Clinuvel Pharmaceuticals (ASX: CUV) Expanding Beyond SCENESSE®?

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction 15.0% Price confirming higher
Trend fit Trend inactive 13.2% over four weeks
Fair value -22.0% Below fair value
Market Dynamics buy signal Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 10
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Kalkine 5
simplywall.st 5
marketscreener.com 1
Kalkine Media 1
Moomoo 1
The Motley Fool Australia 1
Stockhead 1
smallcaps.com.au 1

Event Lens

What the news is about

Classified themes
Market update 8
Earnings 4
Analyst action 2
Guidance 1
Balance sheet 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17